AMBUJACEM
₹580.85-6.3 (-1.07%)
Quarterly ResultsProfit & LossBalance SheetCash Flow
Key Insights
POSITIVE
- Net Sales increased significantly to ₹9888.61 crore in Q1 2025, showing strong demand recovery.
- Operating profit improved to ₹1066.91 crore, indicating better cost management and efficiency.
- Net profit surged to ₹1282.24 crore, reflecting enhanced profitability compared to earlier quarters.
NEGATIVE
- Company experienced a cash flow shortfall with a 10% decrease this year [Dummy Data]
- Company’s strategic partnerships have yet to generate expected growth. [Dummy Data]
- Company’s EBITDA shrank at a CAGR of -8% over the past 3 years. [Dummy Data]
Quarterly Results Data
| Field | Trend | Sep 23 | Dec 23 | Mar 24 | Jun 24 | Sep 24 | Dec 24 | Mar 25 | Jun 25 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7,423.95 | 8,128.80 | 8,893.99 | 8,311.48 | 7,516.11 | 9,328.56 | 9,888.61 | 10,289.10 | |
| Expenses | 6,564.28 | 6,884.54 | 7,741.31 | 7,566.91 | 7,023.49 | 8,347.68 | 8,821.70 | 9,256.69 | |
| Operating Profit | 859.67 | 1,244.26 | 1,152.68 | 744.57 | 492.62 | 980.88 | 1,066.91 | 1,032.41 | |
| Other Income | 476.04 | 193.65 | 233.46 | 354.72 | 374.03 | 1,352.24 | 573.26 | 256.09 | |
| Interest | 61.25 | 70.14 | 92.91 | 67.81 | 66.85 | 66.99 | 14.29 | 67.14 | |
| Depreciation | 380.90 | 417.70 | 453.06 | 467.43 | 551.96 | 663.98 | 786.35 | 861.57 | |
| Profit Before Tax | 1,339.71 | 1,448.12 | 1,601.14 | 1,102.68 | 712.67 | 2,336.07 | 1,779.56 | 1,332.63 | |
| Tax | 352.47 | 358.57 | 75.36 | 313.05 | 239.78 | -284.02 | 497.32 | 362.97 | |
| Net Profit | 987.24 | 1,089.55 | 1,525.78 | 789.63 | 472.89 | 2,620.09 | 1,282.24 | 969.66 | |
| EPS in Rs | 3.99 | 4.14 | 5.31 | 2.67 | 1.85 | 8.59 | 3.88 | 3.20 |